R-9b ACK1 inhibitor

ACK1 inhibitor (R)-9b · TechnoGenesys, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R-9b ACK1 inhibitor, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer [Phase 1]